Supply Chain

Forget the age of the Internet. Whether the healthcare industry realizes it or not, we have now entered the age of theInternet of Things(IoT). Life as we know it is being transformed by the increased, virtual communication among machines. 

Expensive drug-coated stents may hold no long-term benefits over traditional bare-metal versions of the device, according to a study published Tuesday in the New England Journal of Medicine.

The U.S. Food and Drug Administration recently approved Siemens Healthineers' Somatom Drive computed tomography system for use in pediatrics, cardiology, oncology, and emergency medicine.

Mylan recently unveiled a $300 generic version of its EpiPen medication following controversy over the high price of the life-saving treatment. While consumers will pay less for the new unbranded EpiPen, Mylan could actually make more money from the generic…

The U.S. Food and Drug Administration on Tuesday approved Novartis' biosimilar drug Erelzi.

Theranos withdrew its request to gain emergency-use authorization from the FDA for its Zika blood test, according to the Wall Street Journal. An FDA inspection earlier this month found that the company did not have proper patient safety protocols in…

Clayton, Dubilier & Rice, a private investment firm in New York City, will make a significant investment in Drive DeVilbiss Healthcare, a medical device manufacturer based in Port Washington, N.Y.

Claris Injectables, a subsidiary of India-based Claris Lifesciences Limited, earned Food and Drug Administration approval for its flumazenil injectable medication.

 A group of 20 senators responded to Mylan's recent announcement to expand its drug discount program and release a generic version of the injectable medication, following the controversy over the cost of EpiPens, reports The Wall Street Journal.

Flutiform, an asthma medication developed by Britain-based Vectura Group, proved ineffective at treating chronic obstructive pulmonary disease in a recent late-stage trial, reported Reuters.